Background:
Radiation therapy is known to cause acute and long term side effects. Some of those side effects are a major reason of mortality in cancer survivors. Heart disease after radiotherapy for Hodgkin and breast cancer patients is a major cause for mortality that it is offsetting the benefits of treatment (EBCTCG, 2016). In this work, potential benefits of using proton therapy in treatment of medulloblastoma to reduce heart toxicity is discussed and compared with benefit gained in reduction of secondary cancer.
Methods: